GPRC6A Functionality in the Cow: Evidence from Dietary Arginine Supplementation in Early-Lactating Dairy Cows

A useful question in livestock functional genomics is whether a receptor is merely annotated in the bovine genome or whether it participates in real physiological processes in the cow. For GPRC6A, a nutrient-sensing G protein-coupled receptor, a 2025 article in Animal Nutrition adds an important in vivo layer to the evidence.

The study is titled:

“Impacts of dietary arginine supplementation on performance, nutrient digestion and expression of proteins related to milk fatty acid and casein synthesis in early lactating dairy cows.”

The authors are Jing Zhang, Jiaojiao Lang, Lijun Bu, Yapeng Liu, Wenjie Huo, Caixia Pei, and Qiang Liu, from the College of Animal Science, Shanxi Agricultural University, Taigu, Shanxi, China. The paper was published in Animal Nutrition volume 21, pages 267 to 278, in 2025. The article was received on 24 May 2024, revised on 28 August 2024, accepted on 28 October 2024, and made available online on 7 April 2025.

The key question of the paper is whether rumen-protected arginine, abbreviated RPArg, can improve milk production, milk fatty acid synthesis, milk protein synthesis, and mammary gland development in early-lactating dairy cows. For GPRC6A biology, the important part is that the authors measure GPRC6A protein expression in bovine mammary gland tissue and place it upstream of Akt/mTOR signaling.

The evidence supports the following model:

Dietary RPArg → increased mammary GPRC6A protein → Akt/mTOR activation → mammary cell proliferation and biosynthetic activity → increased milk, milk fat, and milk protein outputs

This is not as mechanistically direct as a GPRC6A knockdown experiment. Still, it is valuable because it is conducted in live dairy cows, not only in cultured cells.

1. The study is directly bovine and directly physiological

The first strength of this paper is that it works in actual lactating cows.

The authors used 48 multiparous Chinese Holstein dairy cows. The cows were early in lactation, with an average milk yield of about 34.9 kg/day, body weight around 658 kg, and days in lactation around 16.4 days.

The cows were assigned to four groups:

• Control: no RPArg
• Low RPArg: 20 g/day arginine
• Medium RPArg: 40 g/day arginine
• High RPArg: 60 g/day arginine

The experiment lasted 95 days, including a covariate period, adaptation period, and sampling period.

That design is important. The study is not simply asking whether arginine changes signaling in a dish. It asks whether dietary arginine supplementation changes milk production and mammary gland molecular biology in the cow.

The authors state that their goal was to test whether RPArg could enhance lactation performance, milk fatty acid synthesis, and milk protein synthesis by promoting mammary gland development and the expression of related proteins.

2. RPArg increases milk production and milk-component yields

The first functional layer is the whole-animal phenotype.

The paper reports that dry matter intake was not significantly changed by RPArg. However, milk output increased.

The authors state that actual milk, 4% fat-corrected milk, energy-corrected milk, milk fat, and milk protein increased linearly with RPArg supplementation.

This matters because a receptor-signaling argument is stronger when the molecular pathway is connected to a real physiological output. Here, the output is not abstract. It is milk production.

The core production phenotype is:

More RPArg → more milk, more milk fat yield, more milk protein yield

This establishes that dietary arginine is doing something biologically meaningful in early-lactating cows.

3. RPArg shifts milk fatty-acid production toward mammary de novo fatty-acid synthesis

The second functional layer is milk fatty-acid composition.

The paper reports that RPArg linearly increased the production of de novo fatty acids and mixed-source fatty acids, while reducing preformed fatty acids.

This is a biologically important pattern. In dairy biology, de novo fatty acids are synthesized in the mammary gland. Therefore, increased de novo fatty-acid yield is consistent with increased mammary lipogenic activity.

The table evidence is particularly relevant:

• De novo fatty acids increased from 329.1 g/day in control cows to 408.3 g/day in the medium RPArg group.
• Mixed-source fatty acids increased from 404.0 g/day to 451.8 g/day.
• Preformed fatty acids decreased from 503.9 g/day to 478.3 g/day in the medium RPArg group.

This supports the idea that RPArg affects mammary metabolism, not only total milk volume.

4. Figure 2 directly links RPArg to bovine mammary GPRC6A protein

The most important figure for GPRC6A is Figure 2.

Figure 2 is titled:

“Effects of dietary medium rumen-protected arginine (MRPArg) addition on the Akt-mTOR signaling pathway in bovine mammary glands.”

The figure contains two parts:

Figure 2A: Western blot evidence

Figure 2A shows Western blots for:

• GPRC6A
• Akt
• p-Akt
• mTOR
• p-mTOR
• β-actin

The comparison is between:

• Control cows receiving 0 g/day arginine
• MRPArg cows receiving 40 g/day arginine

The figure shows stronger GPRC6A signal in the MRPArg group, alongside stronger p-Akt and p-mTOR signaling.

Figure 2B: Quantification

Figure 2B quantifies the immune-positive bands for:

• GPRC6A
• p-Akt/Akt
• p-mTOR/mTOR

The bar plot shows that all three are significantly increased in the MRPArg group. The figure caption marks significance at P < 0.01 versus control.

This is the central bovine GPRC6A evidence in the paper.

It shows that dietary arginine supplementation in live cows is associated with increased GPRC6A protein expression in mammary gland tissue and activation of downstream Akt/mTOR signaling.

5. The Results section explicitly states that GPRC6A and Akt/mTOR increased

The Results section gives a direct textual statement corresponding to Figure 2.

The authors report that protein expression levels of GPRC6A, p-Akt/Akt, and p-mTOR/mTOR increased with arginine provision.

This is important because Figure 2 is not an isolated image. The text and quantification interpret the Western blot as a significant increase in GPRC6A-associated signaling.

From a functionality standpoint, this suggests that bovine GPRC6A is responsive to arginine nutrition in mammary tissue and is coupled to a plausible intracellular signaling pathway.

6. Figure 1 shows the mammary-development phenotype that Akt/mTOR could explain

If GPRC6A activates Akt/mTOR, one expected outcome is increased cell proliferation and reduced apoptosis.

That is exactly what the paper tests in Figure 1.

Figure 1 is titled:

“Effects of dietary medium rumen-protected arginine addition on proliferation-related protein expressions in bovine mammary glands.”

Figure 1A

The Western blot includes:

• PCNA
• Cyclin D1
• BCL2
• BAX
• caspase-3
• caspase-9
• β-actin

Figure 1B

The quantification shows that MRPArg increases proliferation and survival markers, while decreasing apoptosis markers.

The Results section reports that 40 g/day arginine as RPArg increased Cyclin D1, PCNA, BCL2, and BCL2/BAX, while decreasing BAX, caspase-3, and caspase-9.

This supports the model that RPArg promotes mammary gland development by stimulating mammary epithelial proliferation and suppressing apoptosis.

The connection to GPRC6A is indirect but biologically coherent:

GPRC6A increase + Akt/mTOR activation + proliferation marker increase = plausible receptor-linked mammary growth response

7. Figure 3 connects the pathway to milk-fat synthesis

The next downstream layer is milk-fat synthesis.

Figure 3 is titled:

“Effects of dietary medium rumen-protected arginine addition on the expressions of proteins related to fatty acid synthesis in bovine mammary glands.”

Figure 3A

The Western blot includes:

• AMPK
• p-AMPK
• PPARγ
• SREBP1
• ACACA
• p-ACACA
• FASN
• SCD1
• β-actin

Figure 3B

The quantification shows increased protein expression of lipogenic regulators and enzymes, including:

• PPARγ
• SREBP1
• p-ACACA/ACACA
• FASN
• SCD1

It also shows reduced p-AMPK/AMPK.

This is important because SREBP1, ACACA, FASN, and SCD1 are central to fatty-acid synthesis and desaturation in mammary tissue.

The Results section states that supplementation with 40 g/day arginine increased PPARG, SREBP1, FASN, and SCD1 and promoted ACACA phosphorylation.

That gives a molecular explanation for the milk fatty-acid data.

The logic becomes:

RPArg → GPRC6A/Akt/mTOR → lipogenic protein expression → increased de novo and mixed-source fatty-acid yields

Again, the paper does not prove that every step is GPRC6A-dependent, but the molecular pattern supports functionality.

8. Figure 4 connects RPArg to milk-protein synthesis

The paper also tests milk-protein signaling.

Figure 4 is titled:

“Effects of dietary medium rumen-protected arginine addition on the expressions of proteins related to milk protein synthesis in bovine mammary glands.”

Figure 4A

The Western blot includes:

• JAK2
• p-JAK2
• STAT5
• p-STAT5
• αs1-casein
• β-casein
• κ-casein
• β-actin

Figure 4B

The quantification shows increased casein proteins and increased phosphorylation ratios for JAK2 and STAT5.

The Results section reports that the 40 g/day RPArg group significantly increased κ-casein, β-casein, and αs1-casein. It also reports higher p-JAK2/JAK2 and p-STAT5/STAT5.

This part is not specifically GPRC6A-centered, but it strengthens the broader physiological argument: RPArg supplementation activates mammary biosynthetic pathways that match the increased milk protein phenotype.

9. The Discussion directly interprets the GPRC6A-Akt/mTOR axis

The Discussion is where the authors explicitly connect the observed bovine GPRC6A increase to arginine signaling.

They write that GPRC6A links arginine with the AKT/mTOR pathway and discuss previous work showing that GPRC6A knockdown inhibits arginine activation of Akt signaling in mammary epithelial cells.

Then the authors make the bovine-specific interpretation:

“Arg addition enhanced the protein expressions of GPRC6A” and stimulated Akt/mTOR phosphorylation.

They further state that arginine affects the AKT-mTOR pathway by activating GPRC6A and regulates bovine mammary epithelial cell proliferation.

This is the strongest interpretive claim in the paper.

It turns the Figure 2 observation into a proposed pathway:

Arginine → GPRC6A activation → Akt/mTOR phosphorylation → mammary epithelial proliferation and biosynthesis

10. The Conclusion explicitly names the GPRC6A-Akt/mTOR pathway

The conclusion is also direct.

The authors conclude that RPArg supplementation activates the GPRC6A-Akt/mTOR signal pathway and promotes proteins connected with cell proliferation, milk fatty-acid synthesis, and milk protein synthesis.

That final statement is important because the authors are not merely saying that GPRC6A changed. They are presenting GPRC6A-Akt/mTOR as part of the mechanism by which RPArg improves mammary function.

11. What this paper proves, and what it does not prove

This paper provides meaningful bovine-specific evidence for GPRC6A functionality, but the strength of evidence should be classified carefully.

What it supports strongly

The study supports that, in lactating dairy cows:

1. RPArg increases milk, milk fat, and milk protein yields.
2. RPArg increases de novo and mixed-source milk fatty-acid yields.
3. RPArg increases mammary GPRC6A protein expression.
4. RPArg increases Akt and mTOR phosphorylation.
5. RPArg increases mammary proliferation markers.
6. RPArg increases mammary lipogenic proteins.
7. RPArg increases casein-related protein expression.
8. The authors interpret these effects through a GPRC6A-Akt/mTOR signaling model.

What it does not directly prove

The study does not include:

• GPRC6A knockdown in bovine mammary tissue
• GPRC6A knockout
• GPRC6A antagonist treatment
• GPRC6A rescue experiment
• direct arginine-GPRC6A binding assay
• immunofluorescence localization of GPRC6A
• receptor-specific cAMP, calcium, β-arrestin, or ERK activation assay

Therefore, the safest conclusion is not that this paper alone proves direct arginine-GPRC6A signaling in cows. Rather, it shows that dietary arginine supplementation in live cows increases mammary GPRC6A protein together with Akt/mTOR activation and milk-biosynthesis outputs.

12. Why this matters for bovine GPRC6A functionality

This paper is valuable because it moves the GPRC6A discussion from cultured cells into the whole animal.

Previous bovine mammary epithelial cell studies provided stronger causal evidence using GPRC6A knockdown. This 2025 dairy cow study adds in vivo support: when arginine is supplied to live cows in a rumen-protected form, mammary gland tissue shows increased GPRC6A protein and increased Akt/mTOR signaling, while milk yield, milk fat yield, milk protein yield, and mammary biosynthetic proteins also increase.

The most balanced interpretation is:

GPRC6A in cattle is supported by both cell-level causal evidence and whole-animal nutritional evidence. This article contributes the whole-animal layer: dietary arginine supplementation is associated with activation of a mammary GPRC6A-Akt/mTOR axis in early-lactating dairy cows.

In short, this paper does not stand alone as a definitive receptor-mechanism study, but it strongly supports the idea that bovine GPRC6A is part of a functional nutrient-responsive mammary signaling network.